Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine plus ciprofol dosing for gastrointestinal endoscopy
ChiCTR2400088969Phase 4Not yet recruiting
- Sponsor
- Dalian Municipal Central Hospital
- Start
- Aug 2024
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine and ciprofol (4 arms), sponsored by Dalian Municipal Central Hospital. Primary endpoints: Mean arterial pressure, Heart rate and 2 more. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
esketamineciprofol
Beyond the preview
Go deeper on ChiCTR2400088969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088969.